1. 'Be water' strategy of liquid lithium sulfide enables 0.2 V potential barrier for high-performance lithium–sulfur batteries. (September 2021) Authors: Zhao, Y.; Zhang, Z.; Wu, R.; Lyu, C.; Zhao, X.; Xu, H.; Xiang, J.; Zha, C.; Ouyang, G.; Wang, L. Journal: Materials today energy Issue: Volume 21(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 'Candidatus Phytoplasma brasiliense'-related strains associated with papaya bunchy top disease in northern Peru represent a distinct geographic lineage. (February 2017) Authors: Wei, W.; Pérez-López, E.; Davis, R.E.; Bermúdez-Díaz, L.; Granda-Wong, C.; Wang, J.; Zhao, Y. Journal: Crop protection Issue: Volume 92(2017) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 000221 PROGESTERONE RECEPTOR-B GENE REACTIVATION IN POORLY DIFFERENTIATED ENDOMETRIAL CANCER CELLS BY EPIGENETIC MODIFICATION REAGENTS. (1st September 2005) Authors: Dowdy, S. C; Xiong, Y.; Gonzalez, J.; Zhao, Y.; Eberhardt, N. L.; Podratz, K. C.; Jiang, S. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research. (December 2022) Authors: Zhao, Y.; Wang, X.; Zhang, M.; Liu, J.; Pu, H.; Li, X.; Zhao, H.; Xu, S.; Yang, M.; Bai, S.; Guo, L.; Zhao, L.; Li, Y.; Wang, Y. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1064‐nm Q‐switched Nd:YAG laser is an effective and safe approach to treat xanthelasma palpebrarum in Asian population. (9th June 2014) Authors: Zhao, Y.; Wen, C.M.; Zhou, N.N.; Feng, Q.; Tu, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 11(2015:Nov.) Page Start: 2263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 136P Tislelizumab (TIS) plus chemotherapy (chemo) for EGFR-mutated non-squamous non-small cell lung cancer (nsq-NSCLC) failed to EGFR tyrosine kinase inhibitors (TKIs) therapies: The primary analysis. (December 2022) Authors: Han, B.; Zhong, H.; Tian, P.; Zhao, Y.; Guo, Q.; Yu, X.; Yu, Z.; Zhang, X.; Li, Y.; Chen, L.; Zhang, Y.; Shi, X.; Wang, J. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 141P Efficacy and safety of tislelizumab combined with targeted therapy as first-line treatment for unresectable hepatocellular carcinoma: A real-world study. (December 2022) Authors: Wang, L.; Zhao, Y.; Zhang, T.; Wang, L. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 149P A phase Ⅰb/Ⅱ trial of surufatinib plus toripalimab and etoposide (E) combined with cisplatin (P) in patients (pts) with untreated advanced small cell lung cancer (SCLC). (December 2022) Authors: Fang, W.F.; Huang, Y.; Yang, Y.; Zhao, Y.; Zhang, Y.; Zhou, T.; Zhao, S.; Yuxiang, M.; Hong, S.D.; Zhao, H.; Zhang, L. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 162P Efficacy and safety of GEMOX (gemcitabine plus oxaliplatin) plus sintilimab and bevacizumab as a conversion therapy in patients with initially unresectable biliary tract cancers (BTC): A single-arm, phase II study. (December 2022) Authors: Zhang, N.; Zhou, J.; Wang, L.; Zhang, T.; Zhu, W.; Mao, A.; Pan, Q.; Lin, Z.; Wang, M.; Zhang, Y.; Feng, Y.; Xu, W.; Zhao, Y.; Wang, L. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 210 DECITABINE TREATMENT COULD AMELIORATE PRIMARY IRON-OVERLOAD IN MYELODYSPLASTIC SYNDROME PATIENTS. Issue 1 (April 2015) Authors: Chunkang, C.; Gu, S.; Zhao, Y.; Guo, J.; Fei, C.; Xv, F.; Xiao, C.; Li, X. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗